Yongqin Wu

Board Certified Neurologist, 2012. ABPN Certificate No 57913 Certified on 9/20/2012 NC Medical Board license number 2012-00566, valid through 1/7/2025.

• Neurology, 07/2010- 07/2012, University of North Carolina, Chapel Hill, NC
• Neurology, 07/2009- 06/2010, University of Kansas Medical Center, Kansas City, KS
• Internship, 07/2008-06/2009, University of Kansas Medical Center, Kansas City, KS

• Powell AW, Sassa T, Wu Y, Tessier-Lavigne M, Polleux F. Topography of thalamic projections requires attractive and repulsive functions of Netrin-1 in the ventral telencephalon. PLoS Biol. 2008 May 13;6(5):e116
• Li M, Wu Y, Caron KM. Haploinsufficiency for adrenomedullin reduces pinopodes and diminishes uterine receptivity in mice. Biol, Reprod, 2008, 79 (6): 1169-75
• Tucker ES, Segall S, Gopalakrishna D, Wu Y, Vernon M, Polleux F, Lamantia AS. Molecular specification and patterning of progenitor cells in the lateral and medial ganglionic eminences. J Neurosci. 2008 Sep 17;28(38):9504-18.
• Meechan DW, Maynard TM, Gopalakrishna D, Wu Y, LaMantia AS. When half is not enough: gene expression and dosage in the 22q11 deletion syndrome. Gene Expr. 2007;13(6):299-310. Review.
• Maynard TM, Meechan DW, Dudevoir ML, Gopalakrishna D, Peters AZ, Heindel CC, Sugimoto TJ, Wu Y, Lieberman JA, Lamantia AS. Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes. Mol Cell Neurosci 2008, 39 (3), 439-51
• Meechan DW, Maynard TM, Gopalakrishna D, Wu Y, LaMantia AS. When half is not enough: gene expression and dosage in the 22q11 deletion syndrome. Gene Expr. 2007; 13(6):299-310.
• Meechan DW, Maynard TM, Wu Y, Gopalakrishna D, Lieberman JA and LaMantia AS. Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. Mol Cell Neurosci. 2006, Nov; 33(4): 412-28.
• Taranova OV, Magness ST, Fagan BM, Wu Y, Surzenko N, Hutton SR, Pevny LH. SOX2 is a dose-dependent regulator of retinal neural progenitor competence. Gene Dev. 2006, May; 20(9): 1187-202.
• Hashimoto T, Wu Y, Lawton M, Yang GY, Barbaro NM, Young WL. Coexpression of angiogenic factors in brain arteriovenous malformations. Neurosurgery. 2005, May; 56(5): 1058-65.
• Hashimoto T, Wu Y, Boudreau N, Li J, Matsumoto M, Young WL. Regulation of tie-2 expression by angiopoietin potential feedback system. Endothelium. 2004, May; 11(3-4): 207-10.
• Xu B, Wu YQ, Huey M, Arthur HM, Marchuk DA, Hashimoto T, Young WL, Yang GY. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab. 2004, Feb; 24(2): 237-44.
• Le DA, Wu Y, Huang Z, Matsushita K, Plesnila N, Augustinack JC, Hyman BT, Yuan J, Kuida K, Flavell RA, Moskowitz MA. (Co-first author). Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci U S A. 2002, Nov; 99(23): 15188-93.
• Peng J, Wu Z, Wu Y, Hsu M, Stevenson FF, Boonplueang R, Roffler-Tarlov SK, Andersen JK. Inhibition of caspases protects cerebellar granule cells of the weaver mouse from apoptosis and improves behavioral phenotype. J Biol Chem. 2002, Nov; 15(277(46)): 44285-91.
• Plesnile N, Zinkel S, Le D, Amin-Hanjani S, Wu Y, Qiu J, Chiarugi A, Thomas S, Kohane D, Korsemeyer S, Moskowitz MA. BID mediates neuronal cell death after oxygen glucose deprivation and focal cerebral ischemia. Proc Natl Acad Sci U S A. 2001, Dec; 98(26): 15318-15323.
• Viswanath V, Wu Y, Boonpluang R, Chen S, Stevensen FF, Yantiri F, Yang L, Beal MF, Andersen JK. (Co-first author). Caspase-9 Activation Results in Downstream Caspase-8 activation and Bid cleavage in MPTP-induced Parkinson's disease. J Neurosci. 2001, Dec; 21(24): 9519-9528.
• Matsushita K, Wu Y, Qiu J, Lang-Lazdunski L, Hirt L, Waeber C, Hyman BT, Yuan J and Moskowitz M.A. Fas receptor and neuronal death after spinal cord ischemia. J Neurosci. 2000, Sep; 20(18): 6879-6887.
• Zhou Z, Wu Y, Ren H, Lu C. Clinical study of P10 mRNA expression in myasthenia gravis. Chin J Neurol. 2000, Feb; 33(1): 20-23.
• Matsushita K, Wu Y, Lang-Lazdunski L, Jacoby LB, Moskowitz MA. Pro-Caspase-8 activation following spinal cord ischemia. Soc Neurosci Abstr. 1999, Oct; -(25):1061.
• Wu Y, Huang Z, Mastushita K, Amin-Hanjani S, Kuida K, Yuan J and Moskowitz MA. Caspase-7 activation after ischemia in caspase-3 deficient mice. Soc Neurosci Abstr. 2000, Oct; -(26):24.
• Wu Y, Lu C. Differential display PCR. Chin J Neurol. 1999, Feb; 32(1): 46-47.
• Wu Y, Lu C, Zhou T, Yang R, Ma L, Pei G. Screening and identification of genes related to myasthenia gravis. Chin J Neurol. 1998, Apr; 31(2): 69-71.
• Wu Y, Song S, Pan R. Experimental study of glucosidorum triptergiitotorum in the treatment of polymyositis. J Chin Nerv Ment Dis. 1997, Jan; 23(1): 29-31.
• Zhou TH, Ren XH, Yin DL, Wu YQ, Li M, Lu CZ, Wu DC, Wu YQ, Peng YQ, Wang YP, Ma L Pei G. Retardation of pain development: a case of recovery from congenital insensitivity to pain. Acta Anaesthesiol Scand. 1997, Sep; 41(8): 1077-1079.
• Wu Y, Lu C. Molecular mechanism of myasthenia gravis. J Foreign Med Sci, Neurological disease. 1997, Apr; 24(6): 281-284.
• Wu Y, Zhou T, Yang R, Ma L, Pei G, Lu C. Screening and identification of genes related to myasthenia gravis by DD-RT-PCR. Acta Academia Medicine Shanghai. 1997, Mar; 24(Suppl):35-39.
• Wu Y, Lu C. Macrophage and its role in nervous system. J Foreign Med Sci, Neurological disease. 1996, Sep; 23(3): 118-121.
• Xiong D, Wu Y, Yang Y. Perforin (Review). J Shanghai Immunology. 1996, Jan; 16(1): 56-59.
• Wu Y, Qiao J, Lu C. TNF level in the serum of myasthenia gravis patients. Shanxi Med and Drug. 1995, Aug; 4(1): 1-3.
• Wu Y, Lu C. Macrophage and neurological disease. Clinical Neuroscience. 1995, Jan; 3(1): 46-49.
• Wu Y, Pan R. Current treatment options in polymyositis (Review). J Foreign Med Sci, Internal Medicine. 1994, Oct; 21(10): 440-442.
• Wu Y, Pan R. Recent advances in the study of polymyositis. J Foreign Med Sci, Neurological disease. 1994, Sep; 21(4): 169-171.